AF
HCAT icon

Amalgamated Financial’s Health Catalyst HCAT Stock Holding History

Amalgamated Financial’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$223K Buy
+8,526
New +$242K ﹤0.01% 1859

Other funds holding HCAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Amalgamated Financial's HCAT Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Health Catalyst (HCAT) in Q1 2022: 8,526 shares worth $223K. The stake represents ﹤0.01% of the portfolio and ranks #1859 among its holdings.

185 funds tracked by Wall St. Rank hold HCAT as of Q1 2022.

  • Amalgamated Financial held 8,526 shares of Health Catalyst worth $223K as of Q1 2022.
  • Health Catalyst was a new Amalgamated Financial position in Q1 2022.
  • Health Catalyst made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1859 holding.
  • 185 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.